Real-World Use of Clopidogrel and Ticagrelor in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries: Patient Characteristics and Long-Term Outcomes

Background: Current guidelines recommend ticagrelor as the preferred P(2)Y(12) inhibitor on top of aspirin in patients after an acute coronary syndrome. Yet, the efficacy and safety of ticagrelor vs. clopidogrel in patients with myocardial infarction with nonobstructive coronary arteries (MINOCA) re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Side, Xu, Haobo, Huang, Sizhuang, Yuan, Jiansong, Yu, Mengyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724121/
https://www.ncbi.nlm.nih.gov/pubmed/34993242
http://dx.doi.org/10.3389/fcvm.2021.807494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724121/
https://www.ncbi.nlm.nih.gov/pubmed/34993242
http://dx.doi.org/10.3389/fcvm.2021.807494

Ejemplares similares